Delayed
Japan Exchange
12:48:21 2024-06-05 am EDT
|
5-day change
|
1st Jan Change
|
723
JPY
|
+0.70%
|
|
+9.21%
|
+42.89%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
40,529
|
23,391
|
30,661
|
20,833
|
21,158
|
29,158
|
-
|
Enterprise Value (EV)
1 |
34,606
|
17,643
|
25,386
|
15,900
|
17,024
|
27,737
|
29,158
|
P/E ratio
|
-122
x
|
-81.5
x
|
-65.7
x
|
-41.8
x
|
-29
x
|
193
x
|
30.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
1.39%
|
1.39%
|
Capitalization / Revenue
|
17.2
x
|
10.1
x
|
13.6
x
|
9.91
x
|
10.4
x
|
11
x
|
6.64
x
|
EV / Revenue
|
17.2
x
|
10.1
x
|
13.6
x
|
9.91
x
|
10.4
x
|
11
x
|
6.64
x
|
EV / EBITDA
|
-176,160,081
x
|
-210,667,532
x
|
-90,543,888
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-82,042,457
x
|
-138,411,062
x
|
-65,654,595
x
|
-60,963,950
x
|
-
|
147,535,993
x
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
-
|
0%
|
-
|
Price to Book
|
5.12
x
|
3.07
x
|
4.28
x
|
3.13
x
|
3.56
x
|
4.56
x
|
4.81
x
|
Nbr of stocks (in thousands)
|
40,610
|
40,610
|
40,610
|
40,610
|
40,610
|
40,610
|
-
|
Reference price
2 |
998.0
|
576.0
|
755.0
|
513.0
|
521.0
|
718.0
|
718.0
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/28/21
|
4/26/22
|
4/27/23
|
4/30/24
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,357
|
2,309
|
2,257
|
2,103
|
2,032
|
2,514
|
4,393
|
EBITDA
|
-230.1
|
-111
|
-338.6
|
-
|
-
|
-
|
-
|
EBIT
1 |
-349
|
-235
|
-466
|
-498
|
-728.1
|
144
|
959
|
Operating Margin
|
-14.81%
|
-10.18%
|
-20.65%
|
-23.68%
|
-35.82%
|
5.73%
|
21.83%
|
Earnings before Tax (EBT)
|
-339
|
-229
|
-462
|
-494
|
-725.5
|
147
|
959
|
Net income
1 |
-333
|
-287
|
-466
|
-497
|
-729.3
|
143
|
959
|
Net margin
|
-14.13%
|
-12.43%
|
-20.65%
|
-23.63%
|
-35.88%
|
5.69%
|
21.83%
|
EPS
2 |
-8.210
|
-7.070
|
-11.49
|
-12.26
|
-17.96
|
3.530
|
23.60
|
Free Cash Flow
|
-494
|
-169
|
-467
|
-341.7
|
-
|
188
|
-
|
FCF margin
|
-20.96%
|
-7.32%
|
-20.69%
|
-16.25%
|
-
|
7.48%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
131.47%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
10.00
|
10.00
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/28/21
|
4/26/22
|
4/27/23
|
4/30/24
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
983
|
916
|
980
|
615
|
422
|
550
|
972
|
471
|
589
|
662.1
|
584.5
|
1,246
|
539
|
729
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-271
|
-272
|
-267
|
-72
|
-267.1
|
-153
|
-420
|
-204
|
-104
|
14.21
|
-25.06
|
-10
|
-40.82
|
194.8
|
Operating Margin
|
-27.57%
|
-29.69%
|
-27.24%
|
-11.71%
|
-63.29%
|
-27.82%
|
-43.21%
|
-43.31%
|
-17.66%
|
2.15%
|
-4.29%
|
-0.8%
|
-7.57%
|
26.73%
|
Earnings before Tax (EBT)
|
-269
|
-270
|
-265
|
-72
|
-267
|
-
|
-419
|
-203
|
-
|
14
|
-
|
-9
|
-41
|
-
|
Net income
|
-271
|
-272
|
-267
|
-73
|
-268
|
-
|
-421
|
-204
|
-
|
13.84
|
-
|
-11
|
-42
|
-
|
Net margin
|
-27.57%
|
-29.69%
|
-27.24%
|
-11.87%
|
-63.51%
|
-
|
-43.31%
|
-43.31%
|
-
|
2.09%
|
-
|
-0.88%
|
-7.79%
|
-
|
EPS
|
-6.680
|
-6.700
|
-6.590
|
-1.800
|
-6.600
|
-
|
-10.38
|
-5.030
|
-
|
0.3400
|
-
|
-0.2900
|
-1.030
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/30/19
|
10/30/20
|
10/29/21
|
1/31/22
|
7/27/22
|
10/31/22
|
10/31/22
|
1/27/23
|
4/27/23
|
7/31/23
|
10/31/23
|
10/31/23
|
1/30/24
|
4/30/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
5,923
|
5,748
|
5,275
|
4,933
|
4,134
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-494
|
-169
|
-467
|
-342
|
-
|
188
|
-
|
ROE (net income / shareholders' equity)
|
-4.1%
|
-3.7%
|
-6.3%
|
-7.2%
|
-11.6%
|
2.4%
|
16.6%
|
ROA (Net income/ Total Assets)
|
-3.81%
|
-2.66%
|
-5.58%
|
-6.29%
|
-10%
|
2.12%
|
-
|
Assets
1 |
8,730
|
10,779
|
8,357
|
7,906
|
7,284
|
6,747
|
-
|
Book Value Per Share
2 |
195.0
|
188.0
|
176.0
|
164.0
|
146.0
|
150.0
|
149.0
|
Cash Flow per Share
|
-5.270
|
-4.010
|
-8.320
|
-9.180
|
-14.70
|
6.820
|
-
|
Capex
|
98
|
85
|
68
|
103
|
142
|
86
|
-
|
Capex / Sales
|
4.16%
|
3.68%
|
3.01%
|
4.88%
|
6.99%
|
3.42%
|
-
|
Announcement Date
|
4/25/19
|
4/27/20
|
4/28/21
|
4/26/22
|
4/27/23
|
4/30/24
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +42.89% | 188M | | +14.21% | 130B | | -7.72% | 11.09B | | -1.95% | 8.56B | | +40.43% | 5.62B | | -27.04% | 4.41B | | +7.47% | 3.41B | | -15.26% | 2.6B | | -12.01% | 2.07B | | -13.56% | 1.92B |
Medical Devices & Implants
|